Hepatology(Liver, Pancreatic, Gall Bladder)

NIH US Elastography for SOS in Pediatric Patients

Conditions:   Sinusoidal Obstruction Syndrome;   Veno Occlusive Disease, Hepatic;   Bone Marrow Transplant Complications;   Stem Cell Transplant Complications
Interventions:   Diagnostic Test: Ultrasound Elastography;   Drug: Contrast Enhanced Ultrasound (CEUS)
Sponsors:   Children’s Mercy Hospital Kansas City;   National Institutes of Health (NIH);   Nationwide Children’s Hospital;   St. Jude Children’s Research Hospital;   Children’s Hospital Colorado
Not yet recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 29, 2019Comments OffElastography | Patients | Pediatric
Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Condition:   Non-Alcoholic Fatty Liver Disease
Interventions:   Drug: TVB-2640;   Other: Placebo
Sponsor:   3V Biosciences, Inc.
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 28, 2019Comments Off2640 | NASH | Nonalcoholic | Steatohepatitis | Study | Subjects
Time Limited Eating in Adolescents With Diabetes (Time LEAD): a Pilot Study

Conditions:   Type 2 Diabetes;   Pre-diabetes;   Obesity, Childhood
Interventions:   Behavioral: Low sugar and carbohydrate diet;   Behavioral: Time Limited Eating;   Device: Continuous Glucose Monitor
Sponsor:   Children’s Hospital Los Angeles
Not yet recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 27, 2019Comments OffAdolescents | Diabetes | Eating | Lead | Limited | Pilot | Study | Time
Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis

Conditions:   Cystic Fibrosis;   Cystic Fibrosis-related Diabetes;   Cystic Fibrosis Liver Disease;   Pancreatic Steatosis;   Hepatic Steatosis
Interventions:   Device: Frequently Sampled Oral Glucose Tolerance Test and CGM;   Radiation: MRI Pancreas and Liver
Sponsor:   University Hospitals Cleveland Medical Center
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 26, 2019Comments OffCharacterization | Correlates | Cystic | Fibrosis | Glycemic | Imaging | Pancreatic
Molecular Basis of Pediatric Liver Cancer

Conditions:   Childhood Liver Cancer;   Liver Malignant Tumors;   Embryonal Sarcoma of Liver (Disorder);   Hepatoblastoma;   Hepatocellular Carcinoma;   Rhabdoid Tumor of Liver
Intervention:  
Sponsor:   University of Pittsburgh
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 25, 2019Comments OffBasis | Cancer | Liver | Molecular | Pediatric
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PSC-Phase 3)

Condition:   Primary Sclerosing Cholangitis
Interventions:   Drug: Cilofexor;   Drug: Placebo
Sponsor:   Gilead Sciences
Recruiting
ClinicalTrials.gov: Hepatology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 24, 2019Comments OffAdults | Cholangitis | Cilofexor | Efficacy | NonCirrhotic | Primary | PSCPhase | Safety | Sclerosing | Tolerability
Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis

Conditions:   Cystic Fibrosis;   Cystic Fibrosis-related Diabetes;   Cystic Fibrosis Liver Disease;   Pancreatic Steatosis;   Hepatic Steatosis
Interventions:   Device: Frequently Sampled Oral Glucose Tolerance Test and CGM;   Radiation: MRI Pancreas and Liver
Sponsor:   University Hospitals Cleveland Medical Center
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 23, 2019Comments OffCharacterization | Correlates | Cystic | Fibrosis | Glycemic | Imaging | Pancreatic